Related references
Note: Only part of the references are listed.Conformational Modulation of Iduronic Acid-Containing Sulfated Glycosaminoglycans by a Polynuclear Platinum Compound and Implications for Development of Antimetastatic Platinum Drugs
Anil K. Gorle et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)
The novel platinum(IV) prodrug with self-assembly property and structure transformable character against triple-negative breast cancer
Conglian Yang et al.
BIOMATERIALS (2020)
Synthesis and biological assessment of a ruthenium(II) cyclopentadienyl complex in breast cancer cells and on the development of zebrafish embryos
Golara Golbaghi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Ferrocene-containing hybrids as potential anticancer agents: Current developments, mechanisms of action and structure-activity relationships
Ruo Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
An Erlotinib gold(I) conjugate for combating triple-negative breast cancer
Enrique Ortega et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2020)
Evaluation of the biological potential of ruthenium(II) complexes with cinnamic acid
Angelica E. Graminha et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2020)
Rationally Designed Ruthenium Complexes for Breast Cancer Therapy
Golara Golbaghi et al.
MOLECULES (2020)
An anticancer gold(III)-activated porphyrin scaffold that covalently modifies protein cysteine thiols
Ka-Chung Tong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Exploring Ovarian Cancer Cell Resistance to Rhenium Anticancer Complexes
Sierra C. Marker et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Isoxazole-Derived Aroylhydrazones and Their Dinuclear Copper(II) Complexes Show Antiproliferative Activity on Breast Cancer Cells with a Potentially Alternative Mechanism Of Action
Jesica Paola Rada et al.
CHEMBIOCHEM (2020)
Selective Coordination Mode of Acylthiourea Ligands in Half-Sandwich Ru(II) Complexes and Their Cytotoxic Evaluation
Beatriz N. Cunha et al.
INORGANIC CHEMISTRY (2020)
Molecular and Cellular Mechanisms of Cytotoxic Activity of Vanadium Compounds against Cancer Cells
Szymon Kowalski et al.
MOLECULES (2020)
A New Family of Iron(II)-Cyclopentadienyl Compounds Shows Strong Activity against Colorectal and Triple Negative Breast Cancer Cells
Adhan Pilon et al.
MOLECULES (2020)
Breast Cancer Chemotherapeutic Options: A General Overview on the Preclinical Validation of a Multi-Target Ruthenium(III) Complex Lodged in Nucleolipid Nanosystems
Maria Grazia Ferraro et al.
CELLS (2020)
Multispecific Platinum(IV) Complex Deters Breast Cancer via Interposing Inflammation and Immunosuppression as an Inhibitor of COX-2 and PD-L1
Suxing Jin et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Vanadium: Risks and possible benefits in the light of a comprehensive overview of its pharmacotoxicological mechanisms and multi-applications with a summary of further research trends
Agnieszka Scibior et al.
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY (2020)
Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies
Antonio Marra et al.
NPJ BREAST CANCER (2020)
Recent progress in small molecule agents for the targeted therapy of triple-negative breast cancer
Rajibul Islam et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Ru(II)-Naphthoquinone complexes with high selectivity for triple-negative breast cancer
Katia M. Oliveira et al.
DALTON TRANSACTIONS (2020)
Synthesis and antiproliferative activity of benzimidazole-based, trinuclear neutral cyclometallated and cationic-chelated ruthenium(II) complexes
Athi Welsh et al.
DALTON TRANSACTIONS (2020)
Potential Anticancer Activity of Auranofin
Takefumi Onodera et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2019)
Anticancer activity of palladium-based complexes against triple-negative breast cancer
Martin Vojtek et al.
DRUG DISCOVERY TODAY (2019)
Unprecedented inhibition of P-gp activity by a novel ruthenium-cyclopentadienyl compound bearing a bipyridine-biotin ligand
Leonor Corte-Real et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Cytotoxic Activity of the Histone Deacetylase 3-Selective Inhibitor Pojamide on MDA-MB-231 Triple-Negative Breast Cancer Cells
Claudio Luparello et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Recent advances in triple negative breast cancer: the immunotherapy era
Antonio Marra et al.
BMC MEDICINE (2019)
NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
Enzo Alessio et al.
MOLECULES (2019)
Ruthenium-Cyclopentadienyl Bipyridine-Biotin Based Compounds: Synthesis and Biological Effect
Leonor Corte-Real et al.
INORGANIC CHEMISTRY (2019)
Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer
Marialuisa Piccolo et al.
SCIENTIFIC REPORTS (2019)
Design of Rhenium Compounds in Targeted Anticancer Therapeutics
Philippe Collery et al.
CURRENT PHARMACEUTICAL DESIGN (2019)
May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?
Cristina P. Matos et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Triple negative breast cancer and platinum-based systemic treatment: a meta-analysis and systematic review
Jessa Gilda P. Pandy et al.
BMC CANCER (2019)
Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy
Xiaoxia Cai et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Role of mitochondria in rescuing glycolytically inhibited subpopulation of triple negative but not hormone-responsive breast cancer cells
Asmaa Reda et al.
SCIENTIFIC REPORTS (2019)
In vivo acute toxicity evaluation and in vitro molecular mechanism study of antiproliferative activity of a novel indole Schiff base β-diiminato manganeseIII complex in hormone-dependent and triple negative breast cancer cells
Reyhaneh Farghadani et al.
PEERJ (2019)
Substitution-Inert Polynuclear Platinum Complexes Act as Potent Inducers of Condensation/Aggregation of Short Single- and Double-Stranded DNA and RNA Oligonucleotides
Jaroslav Malina et al.
CHEMISTRY-A EUROPEAN JOURNAL (2019)
Metal-based antitumor compounds: beyond cisplatin
Peter V. Simpson et al.
FUTURE MEDICINAL CHEMISTRY (2019)
The rhenium(I)-diselenoether anticancer drug targets ROS, TGF-β1, VEGF-A, and IGF-1 in an in vitro experimental model of triple-negative breast cancers
Philippe Collery et al.
INVESTIGATIONAL NEW DRUGS (2019)
Novobiocin-ferrocene conjugates possessing anticancer and antiplasmodial activity independent of HSP90 inhibition
Mziyanda Mbaba et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2019)
Ru(II)/N-N/PPh3 complexes as potential anticancer agents against MDA-MB-231 cancer cells (N-N = diimine or diamine)
Gabriel H. Ribeiro et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2019)
Transport of the Ruthenium Complex [Ru(GA)(dppe)2]PF6 into Triple-Negative Breast Cancer Cells Is Facilitated by Transferrin Receptors
Marina A. Naves et al.
MOLECULAR PHARMACEUTICS (2019)
Non-mutagenic Ru(ii) complexes: cytotoxicity, topoisomerase IB inhibition, DNA and HSA binding
Monize M. da Silva et al.
DALTON TRANSACTIONS (2019)
In vitro cytotoxicity and in vivo zebrafish toxicity evaluation of Ru(ii)/2-mercaptopyrimidine complexes
Vivianne S. Velozo-Sa et al.
DALTON TRANSACTIONS (2019)
Nucleus-enriched Ruthenium Polypyridine Complex Acts as a Potent Inhibitor to Suppress Triple-negative Breast Cancer Metastasis In vivo
Xuanhao Zhao et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2019)
Synthesis, characterization, DFT calculations and anticancer activity of a new oxidovanadium(iv) complex with a ligand derived from o-vanillin and thiophene
Maria R. Rodriguez et al.
NEW JOURNAL OF CHEMISTRY (2019)
A platinum(iv) prodrug to defeat breast cancer through disrupting vasculature and inhibiting metastasis
Yan Guo et al.
DALTON TRANSACTIONS (2019)
Comparison of Neoadjuvant Nab-Paclitaxe plus Carboplatin vs Nab-Paclitaxe plus Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results
Oleg Gluz et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Unprecedented anticancer activities of organorhenium sulfonato and carboxylato complexes against hormone-dependent MCF-7 and hormone-independent triple-negative MDA-MB-231 breast cancer cells
Paul T. Wilder et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2018)
Comparison of Neoadjuvant Nab-Paclitaxe plus Carboplatin vs Nab-Paclitaxe plus Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results
Oleg Gluz et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Selective Inhibition of Lysine-Specific Demethylase 5A (KDM5A) Using a Rhodium(III) Complex for Triple-Negative Breast Cancer Therapy
Guan-Jun Yang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Co-targeting poly(ADP-ribose) polymerase (PARP) and histone deacetylase (HDAC) in triple-negative breast cancer: Higher synergism in BRCA mutated cells
Helene Marijon et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Identification of a rhodium(III) complex as a Wee1 inhibitor against TP53-mutated triple-negative breast cancer cells
Guan-Jun Yang et al.
CHEMICAL COMMUNICATIONS (2018)
Structure-activity relationships for ruthenium and osmium anticancer agents - towards clinical development
Samuel M. Meier-Menches et al.
CHEMICAL SOCIETY REVIEWS (2018)
The trans-[Ru(PPh3)2(N,N-dimethyl-N′-thiophenylthioureato-k2O,S)(bipy)] PF6 complex has pro-apoptotic effects on triple negative breast cancer cells and presents low toxicity in vivo
Amanda Blanque Becceneri et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2018)
Cytotoxic activity and structural features of Ru(II)/phosphine/amino acid complexes
Edjane R. dos Santos et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2018)
Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial
Sibylle Loibl et al.
LANCET ONCOLOGY (2018)
Pharmaco-genomic investigations of organo-iridium anticancer complexes reveal novel mechanism of action
Jessica M. Hearn et al.
METALLOMICS (2018)
Phosphine/diimine ruthenium complexes with Cl-, CO, NO+, NO2-, NO3- and pyridine ligands: Pro-apoptotic activity on triple-negative breast cancer cells and DNA/HSA interactions
Henrique Vieira Reis Silva et al.
POLYHEDRON (2018)
A randomized and open-label phase II trial reports the efficacy of neoadjuvant lobaplatin in breast cancer
Xiujuan Wu et al.
NATURE COMMUNICATIONS (2018)
Towards rational design of RAD51-targeting prodrugs: platinum(IV)-artesunate conjugates with enhanced cytotoxicity against BRCA-proficient ovarian and breast cancer cells
Shuren Zhang et al.
CHEMICAL COMMUNICATIONS (2018)
Half-sandwich Os(ii) and Ru(ii) bathophenanthroline complexes: anticancer drug candidates with unusual potency and a cellular activity profile in highly invasive triple-negative breast cancer cells
Jitka Pracharova et al.
DALTON TRANSACTIONS (2018)
Chlorambucil-conjugated platinum(IV) prodrugs to treat triple-negative breast cancer in vitro and in vivo
Zhong-Ying Ma et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Probing the Anticancer Action of Novel Ferrocene Analogues of MNK Inhibitors
Supojjanee Sansook et al.
MOLECULES (2018)
Non-Platinum Metal Complexes as Potential Anti-Triple Negative Breast Cancer Agents
Eva Maria Dominguez-Martis et al.
CRYSTALS (2018)
Applications of Ruthenium Complex in Tumor Diagnosis and Therapy
Ke Lin et al.
FRONTIERS IN PHARMACOLOGY (2018)
Anti-Proliferative and Anti-Migration Activity of Arene-Ruthenium(II) Complexes with Azole Therapeutic Agents
Legna Colina-Vegas et al.
INORGANICS (2018)
Survival Study of Triple-Negative and Non-Triple-Negative Breast Cancer in a Brazilian Cohort
Homero Goncalves et al.
CLINICAL MEDICINE INSIGHTS-ONCOLOGY (2018)
Palladium(II) Acetylide Complexes with Pincer-Type Ligands: Photophysical Properties, Intermolecular Interactions, and Photo-cytotoxicity
Faan-Fung Hung et al.
CHEMISTRY-AN ASIAN JOURNAL (2017)
Rhodium-Catalyzed [3+2] Annulation of Cyclic N-Acyl Ketimines with Activated Olefins: Anticancer Activity of Spiroisoindolinones
Satyasheel Sharma et al.
JOURNAL OF ORGANIC CHEMISTRY (2017)
A Prodrug of Two Approved Drugs, Cisplatin and Chlorambucil, for Chemo War Against Cancer
Rakesh K. Pathak et al.
MOLECULAR CANCER THERAPEUTICS (2017)
A Liposome Encapsulated Ruthenium Polypyridine Complex as a Theranostic Platform for Triple-Negative Breast Cancer
Jianliang Shen et al.
NANO LETTERS (2017)
Diruthenium(II,III) metallodrugs of ibuprofen and naproxen encapsulated in intravenously injectable polymer-lipid nanoparticles exhibit enhanced activity against breast and prostate cancer cells
Samara R. Alves Rico et al.
NANOSCALE (2017)
Ruthenium(II)/triphenylphosphine complexes: An effective way to improve the cytotoxicity Of lapachol
Katia M. Oliveira et al.
POLYHEDRON (2017)
Sn- and Ge- triorganometallics exert different cytotoxicity and modulation of migration in triple-negative breast cancer cell line MDA-MB-231
Luba Hunakova et al.
TOXICOLOGY LETTERS (2017)
Inhibition of the Ras/Raf interaction and repression of renal cancer xenografts in vivo by an enantiomeric iridium(III) metal-based compound
Li-Juan Liu et al.
CHEMICAL SCIENCE (2017)
Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action
Carlo Irace et al.
SCIENTIFIC REPORTS (2017)
The medicinal chemistry of ferrocene and its derivatives
Malay Patra et al.
NATURE REVIEWS CHEMISTRY (2017)
Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells
Cecilia P. Popolin et al.
PLOS ONE (2017)
Molecular Signatures Associated with Treatment of Triple-Negative MDA-MB231 Breast Cancer Cells with Histone Deacetylase Inhibitors JAHA and SAHA
Mariangela Librizzi et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2017)
The cytotoxicity and mechanism of action of new multinuclear Scaffold AuIII, PdII pincer complexes containing a bis(diphenylphosphino) ferrocene/non-ferrocene ligand
Leila Tabrizi et al.
DALTON TRANSACTIONS (2017)
Half sandwich Ru(II)-acylthiourea complexes: DNA/HSA-binding, anti-migration and cell death in a human breast tumor cell line
Legna Colina-Vegas et al.
DALTON TRANSACTIONS (2017)
Biotin-tagged platinum(IV) complexes as targeted cytostatic agents against breast cancer cells
Nafees Muhammad et al.
CHEMICAL COMMUNICATIONS (2017)
A palladium(II)-saccharinate complex of terpyridine exerts higher anticancer potency and less toxicity than cisplatin in a mouse allograft model
Yuksel Cetin et al.
ANTI-CANCER DRUGS (2017)
New Acridine Thiourea Gold(I) Anticancer Agents: Targeting the Nucleus and Inhibiting Vasculogenic Mimicry
Sergio A. Perez et al.
ACS CHEMICAL BIOLOGY (2017)
Exploring the Influence of the Aromaticity on the Anticancer and Antivascular Activities of Organoplatinum(II) Complexes
Ana Zamora et al.
CHEMISTRY-A EUROPEAN JOURNAL (2017)
The role of cell cycle progression for the apoptosis of cancer cells induced by palladium(II)-saccharinate complexes of terpyridine
Omer Kacar et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
In vitro anticancer activity evaluation of new cationic platinum(II) complexes based on imidazole moiety
Isabella Rimoldi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Differential Cytotoxicity, Cellular Uptake, Apoptosis and Inhibition of BRCA1 Expression of BRCA1-Defective and Sporadic Breast Cancer Cells Induced by an Anticancer Ruthenium(II)-Arene Compound, RAPTA-EA1
Adisorn Ratanaphan et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2017)
Novel ferrocenyl pyrazoles inhibit breast cancer cell viability via induction of apoptosis and inhibition of PI3K/Akt and ERK1/2 signaling
Harika Atmaca et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
Anticancer Gold(III) Porphyrins Target Mitochondrial Chaperone Hsp60
Di Hu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Ferrocene-substituted 3,3′-diindolylmethanes with improved anticancer activity
Julienne K. Muenzner et al.
APPLIED ORGANOMETALLIC CHEMISTRY (2016)
Synthesis and structure-activity relationships of novel hybrid ferrocenyl compounds based on a bicyclic core skeleton for breast cancer therapy
Changhao Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
The water soluble ruthenium(II) organometallic compound [Ru(p-cymene)(bis(3,5 dimethylpyrazol-1-yl)methane)Cl]Cl suppresses triple negative breast cancer growth by inhibiting tumor infiltration of regulatory T cells
Maura Montani et al.
PHARMACOLOGICAL RESEARCH (2016)
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
Brian D. Lehmann et al.
PLOS ONE (2016)
Biological Effect of a Hybrid Anticancer Agent Based on Kinase and Histone Deacetylase Inhibitors on Triple-Negative (MDA-MB231) Breast Cancer Cells
Mariangela Librizzi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
The palladacycle, AJ-5, exhibits anti-tumour and anti-cancer stem cell activity in breast cancer cells
Saeb Aliwaini et al.
CANCER LETTERS (2015)
Biologically active [Pd2L4](4+) quadruply-stranded helicates: stability and cytotoxicity
Samantha M. McNeill et al.
DALTON TRANSACTIONS (2015)
Three-dimensional and co-culture models for preclinical evaluation of metal-based anticancer drugs
Ekaterina Schreiber-Brynzak et al.
INVESTIGATIONAL NEW DRUGS (2015)
Cytotoxicity of Ru(II) piano-stool complexes with chloroquine and chelating ligands against breast and lung tumor cells: Interactions with DNA and BSA
Legna Colina-Vegas et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2015)
Cyclometalated Iminophosphorane Gold(III) and Platinum(II) Complexes. A Highly Permeable Cationic Platinum(II) Compound with Promising Anticancer Properties
Malgorzata Frik et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial
Xi-Chun Hu et al.
LANCET ONCOLOGY (2015)
RNA-seq analysis of the whole transcriptome of MDA-MB-231 mammary carcinoma cells exposed to the antimetastatic drug NAMI-A
Alberta Bergamo et al.
METALLOMICS (2015)
Ruthenium Polypyridyl Complex Inhibits Growth and Metastasis of Breast Cancer Cells by Suppressing FAK signaling with Enhancement of TRAIL-induced Apoptosis
Wenqiang Cao et al.
SCIENTIFIC REPORTS (2015)
The Proteomic Landscape of Triple-Negative Breast Cancer
Robert T. Lawrence et al.
CELL REPORTS (2015)
Apoptosis-inducing effect of a palladium(II) saccharinate complex of terpyridine on human breast cancer cells in vitro and in vivo
Ferda Ari et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Cellular responses of BRCA1-defective and triple-negative breast cancer cells and in vitro BRCA1 interactions induced by metallo-intercalator ruthenium(II) complexes containing chloro-substituted phenylazopyridine
Tidarat Nhukeaw et al.
BMC CANCER (2014)
Association of race/ethnicity, socioeconomic status, and breast cancer subtypes in the National Cancer Data Base (2010-2011)
Helmneh M. Sineshaw et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
A cytotoxic and cytostatic gold(III) corrole
Ruijie D. Teo et al.
CHEMICAL COMMUNICATIONS (2014)
Conjugates of Cisplatin and Cyclooxygenase Inhibitors as Potent Antitumor Agents Overcoming Cisplatin Resistance
Wilma Neumann et al.
CHEMMEDCHEM (2014)
Cytotoxic Triosmium Carbonyl Clusters: A Structure-Activity Relationship Study
Hui Zhi Shirley Lee et al.
CHEMMEDCHEM (2014)
Anticancer activity of structurally related ruthenium(II) cyclopentadienyl complexes
Leonor Corte-Real et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2014)
Multi-targeted organometallic ruthenium(II)-arene anticancer complexes bearing inhibitors of poly(ADP-ribose) polymerase-1: A strategy to improve cytotoxicity
Zhigang Wang et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2014)
New water-soluble ruthenium(II) cytotoxic complex: Biological activity and cellular distribution
Tania S. Morais et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2014)
In Vitro and in Vivo Evaluation of Water-Soluble Iminophosphorane Ruthenium(II) Compounds. A Potential Chemotherapeutic Agent for Triple Negative Breast Cancer
Malgorzata Frik et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Ferrocenyl derivatives of pterocarpene and coumestan: Synthesis, structure and anticancer activity studies
Konrad Kowalski et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2014)
Biochemical and Proteomic Analysis of a Potential Anticancer Agent: Palladium(II) Saccharinate Complex of Terpyridine Acting through Double Strand Break Formation
Zelal Adiguzel et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial
Gunter von Minckwitz et al.
LANCET ONCOLOGY (2014)
Gold(III)-Dithiocarbamato Peptidomimetics in the Forefront of the Targeted Anticancer Therapy: Preclinical Studies against Human Breast Neoplasia
Chiara Nardon et al.
PLOS ONE (2014)
Gold(III) complexes inhibit growth of cisplatin-resistant ovarian cancer in association with upregulation of proapoptotic PMS2 gene
Ching Tung Lum et al.
CHEMICAL SCIENCE (2014)
A novel binuclear palladacycle complex inhibits melanoma growth in vitro and in vivo through apoptosis and autophagy
Saeb Aliwaini et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Palladium(II) saccharinate complexes with bis(2-pyridylmethyl) amine induce cell death by apoptosis in human breast cancer cells in vitro
Ferda Ari et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Cellular Uptake Mechanisms of an Antitumor Ruthenium Compound: The Endosomal/Lysosomal System as a Target for Anticancer Metal-Based Drugs
Leonor Corte-Real et al.
MICROSCOPY AND MICROANALYSIS (2013)
Synthesis, Characterization, and Antiproliferative Activities of Novel Ferrocenophanic Suberamides against Human Triple-Negative MDA-MB-231 and Hormone-Dependent MCF-7 Breast Cancer Cells
Jose de Jesus Cazares-Marinero et al.
ORGANOMETALLICS (2013)
Synthesis, crystal structure, electronic spectroscopy, electrochemistry and biological studies of carbohydrate containing ferrocene amides
Rajiv Trivedi et al.
APPLIED ORGANOMETALLIC CHEMISTRY (2012)
Synthesis and cytotoxic activities of estrone and estradiol cis-dichloroplatinum(II) complexes
Miroslav Kvasnica et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Cytotoxic Effects of Jay Amin Hydroxamic Acid (JAHA), a Ferrocene-Based Class I Histone Deacetylase Inhibitor, on Triple-Negative MDA-MB231 Breast Cancer Cells
Mariangela Librizzi et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2012)
Coinage Metal Complexes Against Breast Cancer
B. Biersack et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Ferrocenyl catechols: synthesis, oxidation chemistry and anti-proliferative effects on MDA-MB-231 breast cancer cells
Yong Leng Kelvin Tan et al.
DALTON TRANSACTIONS (2012)
In vitro inhibitory properties of ferrocene-substituted chalcones and aurones on bacterial and human cell cultures
Keshri Nath Tiwari et al.
DALTON TRANSACTIONS (2012)
Synthesis of organometallic ruthenium(II) complexes with strong activity against several human cancer cell lines
Tania S. Morais et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
Synthesis, Characterisation and Biological Evaluation of Copper and Silver Complexes based on Acetylsalicylic Acid
Gerhard Rubner et al.
ARCHIV DER PHARMAZIE (2011)
Triple-Negative Breast Cancer in Hispanic Patients High Prevalence, Poor Prognosis, and Association With Menopausal Status, Body Mass Index, and Parity
Fernando Lara-Medina et al.
CANCER (2011)
Synthesis and biological studies of silver N-heterocyclic carbene complexes derived from 4,5-diarylimidazole
Wukun Liu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Anti-cancer activity of a novel palladium(II) complex on human breast cancer cells in vitro and in vivo
Engin Ulukaya et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
NHC Gold Halide Complexes Derived from 4,5-Diarylimidazoles: Synthesis, Structural Analysis, and Pharmacological Investigations as Potential Antitumor Agents
Wukun Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Visualising gold inside tumour cells following treatment with an antitumour gold(I) complex
Louise E. Wedlock et al.
METALLOMICS (2011)
A Gold(III) Porphyrin Complex with Antitumor Properties Targets the Wnt/beta-catenin Pathway
Kim Hei-Man Chow et al.
CANCER RESEARCH (2010)
Synthesis, Cytotoxicity, and COMPARE Analysis of Ferrocene and [3]Ferrocenophane Tetrasubstituted Olefin Derivatives against Human Cancer Cells
Meral Goermen et al.
CHEMMEDCHEM (2010)
Synthesis, electrochemical studies and anticancer activity of ferrocenyl oxindoles
Barbara V. Silva et al.
DALTON TRANSACTIONS (2010)
Synthesis, structure and cytotoxicity studies of four-coordinate bis (cis-bis (diphenylphosphino)ethene) gold(I) complexes, [Au(dppey)2]X
Peter C. Healy et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2010)
Breast Cancer in Latinas: Gene Expression, Differential Response to Treatments, and Differential Toxicities in Latinas Compared with Other Population Groups
Tejal A. Patel et al.
ONCOLOGIST (2010)
Gold (III) Porphyrin Complexes Induce Apoptosis and Cell Cycle Arrest and Inhibit Tumor Growth in Colon Cancer
Shuiping Tu et al.
CANCER (2009)
The tumor proteasome as a novel target for gold(III) complexes: Implications for breast cancer therapy
Vesna Milacic et al.
COORDINATION CHEMISTRY REVIEWS (2009)
VP-128, a novel oestradiol-platinum(II) hybrid with selective anti-tumour activity towards hormone-dependent breast cancer cells in vivo
Celine Van Themsche et al.
ENDOCRINE-RELATED CANCER (2009)
Induction of apoptosis by hexaosmium carbonyl clusters
Kien Voon Kong et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2009)
Ni(II), Cu(II), and Zn(II) Diethyldithiocarbamate Complexes Show Various Activities Against the Proteasome in Breast Cancer Cells
Boris Cvek et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers
Wataru Sakai et al.
NATURE (2008)
Improved synthesis of unique estradiol-linked platinum(II) complexes showing potent cytocidal activity and affinity for the estrogen receptor alpha and beta
Caroline Descoteaux et al.
STEROIDS (2008)
Pyrrolidine dithiocarbamate-zinc(II) and -copper(II) complexes induce apoptosis in tumor cells by inhibiting the proteasomal activity
Vesna Milacic et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2008)
A gold(I) phosphine complex selectively induces apoptosis in breast cancer cells: Implications for anticancer therapeutics targeted to mitochondria
Oliver Rackham et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Gold(I) chloride adducts of 1,3-bis(di-2-pyridylphosphino) propane: synthesis, structural studies and antitumour activity
Anthony S. Humphreys et al.
DALTON TRANSACTIONS (2007)
A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts
Vesna Milacic et al.
CANCER RESEARCH (2006)
Gold(III) dithiocarbamate derivatives for the treatment of cancer:: Solution chemistry, DNA binding, and hemolytic properties
L Ronconi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes
C Scolaro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Synthesis of 17β-estradiol-linked platinum(II) complexes and their cytocidal activity on estrogen-dependent and -independent breast tumor cells
V Perron et al.
BIOORGANIC CHEMISTRY (2005)
Transferrin binding and transferrin-mediated cellular uptake of the ruthenium coordination compound KP1019, studied by means of AAS, ESI-MS and CD spectroscopy
M Pongratz et al.
JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY (2004)
Differences in breast cancer stage, treatment, and survival by race and ethnicity
CI Li et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Gold(III) porphyrins as a new class of anticancer drugs: cytotoxicity, DNA binding and induction of apoptosis in human cervix epitheloid cancer cells
CM Che et al.
CHEMICAL COMMUNICATIONS (2003)
Share Paper
